J 2013

The role of microRNAs in mitochondria in cancer

BIENERTOVÁ VAŠKŮ, Julie, Jiří ŠÁNA and Ondřej SLABÝ

Basic information

Original name

The role of microRNAs in mitochondria in cancer

Authors

BIENERTOVÁ VAŠKŮ, Julie (203 Czech Republic, belonging to the institution), Jiří ŠÁNA (203 Czech Republic, belonging to the institution) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution)

Edition

Cancer Letters, OXFORD, ELSEVIER, 2013, 0304-3835

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30200 3.2 Clinical medicine

Country of publisher

Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.016

RIV identification code

RIV/00216224:14740/13:00065603

Organization unit

Central European Institute of Technology

UT WoS

000321477800001

Keywords in English

microRNA; mitochondria; Krebs cycle; apoptosis; mitophagy

Tags

Tags

International impact, Reviewed
Změněno: 5/4/2014 17:13, Olga Křížová

Abstract

V originále

Reprogramming of the energy metabolism in cancer cell presents progressive field of cancer research. This feature is associated mainly with the mitochondria, which is major energy source of eukaryotic cells. These organelles are essential to the cell homeostasis maintenance, play an important role in intrinsic apoptotic pathway and their dysfunction is associated with multiple diseases including cancer. Recently, it was described that microRNAs (miRNAs) regulate important signaling pathways in mitochondria and many of these miRNAs are deregulated in various cancers. Here we summarize current knowledge about miRNAs involved in mitochondrial functioning with focus on cellular energy metabolism, apoptosis and mitophagy.

Links

ED1.1.00/02.0068, research and development project
Name: CEITEC - central european institute of technology
NT13514, research and development project
Name: Analýza mikroRNA v glioblastomových kmenových buňkách: predikce léčebné odpovědi a identifikace nových terapeutických cílů u pacientů s glioblastomem